FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 77 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $452,000 | +20.5% | 135,701 | +10.0% | 0.00% | – |
Q3 2019 | $375,000 | +21.0% | 123,402 | -5.2% | 0.00% | – |
Q2 2019 | $310,000 | -43.3% | 130,202 | -10.7% | 0.00% | – |
Q1 2019 | $547,000 | +0.9% | 145,802 | -3.3% | 0.00% | – |
Q4 2018 | $542,000 | -28.8% | 150,800 | +13.5% | 0.00% | – |
Q3 2018 | $761,000 | +50.4% | 132,900 | +31.7% | 0.00% | – |
Q2 2018 | $506,000 | +17.1% | 100,887 | +19.8% | 0.00% | – |
Q1 2018 | $432,000 | -26.0% | 84,182 | -13.3% | 0.00% | – |
Q4 2017 | $584,000 | +120.4% | 97,101 | +103.1% | 0.00% | – |
Q3 2017 | $265,000 | +2108.3% | 47,801 | +1738.5% | 0.00% | – |
Q2 2017 | $12,000 | 0.0% | 2,600 | 0.0% | 0.00% | – |
Q1 2017 | $12,000 | +100.0% | 2,600 | +420.0% | 0.00% | – |
Q4 2016 | $6,000 | +20.0% | 500 | -4.4% | 0.00% | – |
Q3 2016 | $5,000 | -94.2% | 523 | -96.3% | 0.00% | – |
Q1 2016 | $86,000 | -67.3% | 14,184 | -56.3% | 0.00% | – |
Q4 2015 | $263,000 | +139.1% | 32,430 | +116.4% | 0.00% | – |
Q3 2015 | $110,000 | +816.7% | 14,989 | +1224.1% | 0.00% | – |
Q2 2015 | $12,000 | -79.3% | 1,132 | -82.0% | 0.00% | – |
Q1 2015 | $58,000 | – | 6,280 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |